Victory Capital Management Inc Aquestive Therapeutics, Inc. Transaction History
Victory Capital Management Inc
- $153 Billion
- Q3 2025
A detailed history of Victory Capital Management Inc transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 12,794 shares of AQST stock, worth $68,959. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,794
Previous 10,932
17.03%
Holding current value
$68,959
Previous $36,000
97.22%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AQST
# of Institutions
178Shares Held
66.4MCall Options Held
794KPut Options Held
457K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$52.9 Million100.0% of portfolio
-
Rtw Investments, LP New York, NY6.25MShares$33.7 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$31.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$29.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$20.3 Million0.05% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $288M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...